Publishing research using ab88503? Please let us know so that we can cite the reference in this datasheet.
ab88503 has been referenced in 2 publications.
Angelika Ihle M et al.HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.J Pathol Clin Res 2:59-71 (2016).
Yeo W et al.Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.J Clin Oncol 30:3361-7 (2012).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up